Paper22992134
Antisense-induced messenger depletion corrects a COL6A2 dominant mutation in Ullrich myopathy.
Gualandi F and 10 others. Hum Gene Ther, 2012. Cited by 26 papers, by iCite.
Cite this record
ConductScience Library. Antisense-induced messenger depletion corrects a COL6A2 dominant mutation in Ullrich myopathy. Papers, record 22992134. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/22992134
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Antisense-induced messenger depletion corrects a COL6A2 dominant mutation in Ullrich myopathy.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Collagen Type VI | Major topic |
| Muscular Dystrophies | Major topic |
| Mutation | Major topic |
| Oligoribonucleotides, Antisense | Major topic |
| Cells, Cultured | |
| Exons | |
| Extracellular Matrix | |
| Fibroblasts | |
| Genes, Dominant | |
| Humans | |
| Nonsense Mediated mRNA Decay | |
| Polymorphism, Single Nucleotide |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| GUP07004 | Telethon | Italy | PubMed |
Source PubMed
References19
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 20302629 | Identification of a deep intronic mutation in the COL6A2 gene by a novel custom oligonucleotide CGH array designed to explore allelic and genetic heterogeneity in collagen VI-related myopathies. | BMC Med Genet | 2010 | https://conductscience.org/library/papers/20302629 | PubMed |
| 2 | 19760747 | Exon skipping-mediated dystrophin reading frame restoration for small mutations. | Hum Mutat | 2009 | https://conductscience.org/library/papers/19760747 | PubMed |
| 3 | 22454058 | Overview on AON design. | Methods Mol Biol | 2012 | https://conductscience.org/library/papers/22454058 | PubMed |
| 4 | 21909428 | Targeting several CAG expansion diseases by a single antisense oligonucleotide. | PLoS One | 2011 | https://conductscience.org/library/papers/21909428 | PubMed |
| 5 | 21784508 | Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study. | Lancet | 2011 | https://conductscience.org/library/papers/21784508 | PubMed |
| 6 | 22172424 | Congenital muscular dystrophies: a brief review. | Semin Pediatr Neurol | 2011 | https://conductscience.org/library/papers/22172424 | PubMed |
| 7 | 20544328 | Delivery of siRNA therapeutics: barriers and carriers. | AAPS J | 2010 | https://conductscience.org/library/papers/20544328 | PubMed |
| 8 | 20211562 | 166th ENMC International Workshop on Collagen type VI-related Myopathies, 22-24 May 2009, Naarden, The Netherlands. | Neuromuscul Disord | 2010 | https://conductscience.org/library/papers/20211562 | PubMed |
| 9 | 17886299 | Molecular consequences of dominant Bethlem myopathy collagen VI mutations. | Ann Neurol | 2007 | https://conductscience.org/library/papers/17886299 | PubMed |
| 10 | 19906562 | RNA-targeting approaches for neuromuscular diseases. | Trends Mol Med | 2009 | https://conductscience.org/library/papers/19906562 | PubMed |
| 11 | 21428760 | Systemic administration of PRO051 in Duchenne's muscular dystrophy. | N Engl J Med | 2011 | https://conductscience.org/library/papers/21428760 | PubMed |
| 12 | 21943391 | ColVI myopathies: where do we stand, where do we go? | Skelet Muscle | 2011 | https://conductscience.org/library/papers/21943391 | PubMed |
| 13 | 12218063 | Effects on collagen VI mRNA stability and microfibrillar assembly of three COL6A2 mutations in two families with Ullrich congenital muscular dystrophy. | J Biol Chem | 2002 | https://conductscience.org/library/papers/12218063 | PubMed |
| 14 | 21280092 | Large genomic deletions: a novel cause of Ullrich congenital muscular dystrophy. | Ann Neurol | 2011 | https://conductscience.org/library/papers/21280092 | PubMed |
| 15 | 11691587 | Collagen VI deficiency affects the organization of fibronectin in the extracellular matrix of cultured fibroblasts. | Matrix Biol | 2001 | https://conductscience.org/library/papers/11691587 | PubMed |
| 16 | 19935778 | First-in-human mutation-targeted siRNA phase Ib trial of an inherited skin disorder. | Mol Ther | 2010 | https://conductscience.org/library/papers/19935778 | PubMed |
| 17 | 19309692 | Identification and characterization of novel collagen VI non-canonical splicing mutations causing Ullrich congenital muscular dystrophy. | Hum Mutat | 2009 | https://conductscience.org/library/papers/19309692 | PubMed |
| 18 | 17604456 | Modulating the expression of disease genes with RNA-based therapy. | PLoS Genet | 2007 | https://conductscience.org/library/papers/17604456 | PubMed |
| 19 | 21037586 | Autophagy is defective in collagen VI muscular dystrophies, and its reactivation rescues myofiber degeneration. | Nat Med | 2010 | https://conductscience.org/library/papers/21037586 | PubMed |
Cited by20
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 26 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40308063 | Clinical applications of exon-skipping antisense oligonucleotides in neuromuscular diseases. | Mol Ther | 2025 | https://conductscience.org/library/papers/40308063 | PubMed |
| 39595588 | Restored Collagen VI Microfilaments Network in the Extracellular Matrix of CRISPR-Edited Ullrich Congenital Muscular Dystrophy Fibroblasts. | Biomolecules | 2024 | https://conductscience.org/library/papers/39595588 | PubMed |
| 39171142 | Allele-specific CRISPR-Cas9 editing inactivates a single nucleotide variant associated with collagen VI muscular dystrophy. | Mol Ther Nucleic Acids | 2024 | https://conductscience.org/library/papers/39171142 | PubMed |
| 38993932 | Strategies to improve the design of gapmer antisense oligonucleotide on allele-specific silencing. | Mol Ther Nucleic Acids | 2024 | https://conductscience.org/library/papers/38993932 | PubMed |
| 38617974 | Optimized allele-specific silencing of the dominant-negative COL6A1 G293R substitution causing collagen VI-related dystrophy. | Mol Ther Nucleic Acids | 2024 | https://conductscience.org/library/papers/38617974 | PubMed |
| 36401021 | Current Strategies of Muscular Dystrophy Therapeutics: An Overview. | Methods Mol Biol | 2023 | https://conductscience.org/library/papers/36401021 | PubMed |
| 35457228 | CRISPR/Cas9-Mediated Allele-Specific Disruption of a Dominant COL6A1 Pathogenic Variant Improves Collagen VI Network in Patient Fibroblasts. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35457228 | PubMed |
| 33441455 | Association of Initial Maximal Motor Ability With Long-term Functional Outcome in Patients With COL6-Related Dystrophies. | Neurology | 2021 | https://conductscience.org/library/papers/33441455 | PubMed |
| 32585628 | Exon-Skipping Oligonucleotides Restore Functional Collagen VI by Correcting a Common COL6A1 Mutation in Ullrich CMD. | Mol Ther Nucleic Acids | 2020 | https://conductscience.org/library/papers/32585628 | PubMed |
| 31447096 | Pathogenic Abnormal Splicing Due to Intronic Deletions that Induce Biophysical Space Constraint for Spliceosome Assembly. | Am J Hum Genet | 2019 | https://conductscience.org/library/papers/31447096 | PubMed |
| 31387942 | Basement membrane collagens and disease mechanisms. | Essays Biochem | 2019 | https://conductscience.org/library/papers/31387942 | PubMed |
| 31083481 | Antisense Oligonucleotide-Based Downregulation of the G56R Pathogenic Variant Causing NR2E3-Associated Autosomal Dominant Retinitis Pigmentosa. | Genes (Basel) | 2019 | https://conductscience.org/library/papers/31083481 | PubMed |
| 30895940 | A recurrent COL6A1 pseudoexon insertion causes muscular dystrophy and is effectively targeted by splice-correction therapies. | JCI Insight | 2019 | https://conductscience.org/library/papers/30895940 | PubMed |
| 28918041 | Gapmer Antisense Oligonucleotides Suppress the Mutant Allele of COL6A3 and Restore Functional Protein in Ullrich Muscular Dystrophy. | Mol Ther Nucleic Acids | 2017 | https://conductscience.org/library/papers/28918041 | PubMed |
| 26945058 | Deep RNA profiling identified CLOCK and molecular clock genes as pathophysiological signatures in collagen VI myopathy. | J Cell Sci | 2016 | https://conductscience.org/library/papers/26945058 | PubMed |
| 25204870 | Mosaicism for dominant collagen 6 mutations as a cause for intrafamilial phenotypic variability. | Hum Mutat | 2015 | https://conductscience.org/library/papers/25204870 | PubMed |
| 24959844 | Allele-specific Gene Silencing of Mutant mRNA Restores Cellular Function in Ullrich Congenital Muscular Dystrophy Fibroblasts. | Mol Ther Nucleic Acids | 2014 | https://conductscience.org/library/papers/24959844 | PubMed |
| 24563484 | A mouse model for dominant collagen VI disorders: heterozygous deletion of Col6a3 Exon 16. | J Biol Chem | 2014 | https://conductscience.org/library/papers/24563484 | PubMed |
| 24518369 | siRNA-mediated Allele-specific Silencing of a COL6A3 Mutation in a Cellular Model of Dominant Ullrich Muscular Dystrophy. | Mol Ther Nucleic Acids | 2014 | https://conductscience.org/library/papers/24518369 | PubMed |
| 24038877 | Position of glycine substitutions in the triple helix of COL6A1, COL6A2, and COL6A3 is correlated with severity and mode of inheritance in collagen VI myopathies. | Hum Mutat | 2013 | https://conductscience.org/library/papers/24038877 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| COL6A2 | 1292 | PubTator's text mining | https://conductscience.org/library/genes/1292 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/22992134
GET https://conductscience.org/api/papers/v1/22992134/authors